Experimental gel could prevent genital herpes infection
(HealthDay)—A drug applied as a vaginal gel may substantially cut women's risk of contracting genital herpes, a common and incurable sexually transmitted infection.
Aug 6, 2015
2
76
(HealthDay)—A drug applied as a vaginal gel may substantially cut women's risk of contracting genital herpes, a common and incurable sexually transmitted infection.
Aug 6, 2015
2
76
A monthly injection of an experimental anti-retroviral drug protected female monkeys from vaginal infection by a simian form of HIV, according to two new studies.
Jan 15, 2015
1
76
Most women are infected with HIV through vaginal intercourse, and without effective vaccines or microbicides, women who cannot negotiate condom use by their partners remain vulnerable. How exactly the virus establishes infection ...
Oct 9, 2014
0
0
An early phase clinical trial of a vaginal ring containing the antiretroviral (ARV) drugs dapivirine and maraviroc found the ring was safe in women who wore it for 28 days and evidence of dapivirine in cervical tissue and ...
Mar 4, 2014
0
0
NIH-funded scientists have shown that boosting the production of certain broadly neutralizing antibodies can protect humanized mice from both intravenous and vaginal infection with HIV. Humanized mice have immune systems ...
Feb 11, 2014
0
0
(Medical Xpress)—New research has shown that a common vaginal infection, often regarded as minor, is having a major effect on women's lives, with recurrent sufferers avoiding sex and even social activities.
Sep 11, 2013
0
0
Infection by human immunodeficiency virus (HIV) causes acquired immunodeficiency syndrome (AIDS), a debilitating disorder in which progressive weakening of the immune system makes affected individuals more susceptible to ...
Aug 15, 2013
0
0
(Medical Xpress)—New research at Washington University School of Medicine in St. Louis points to a common species of bacteria as an important contributor to bacterial vaginosis, a condition linked to preterm birth and increased ...
Apr 23, 2013
0
0
Results of a major HIV prevention trial suggest that daily use of a product – whether a vaginal gel or an oral tablet – does not appear to be the right approach for preventing HIV in young, unmarried African women.
Mar 4, 2013
0
0
Having suggested in 2011 that the urethra is a novel entry site for HIV, a team from the Institut Cochin (CNRS/Inserm/Université Paris Descartes, with the support of Anrs), has now confirmed this hypothesis and identified ...
Mar 1, 2013
0
0